Related Experiment Video
Updated: Aug 12, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
The rise and fall of genomic methylation in cancer
1The Alfred Medical Research and Education Precinct (AMREP), Epigenetics in Human Health and Disease Laboratory, Baker Medical Research Institute, Prahran, Victoria, Australia. assam.el-osta@baker.edu.au
Abstract:
Changes in genomic methylation and its significance in carcinogenesis is in the spotlight once again, though the focus is not on the usual suspects, DNA hypermethylation and tumour suppressor gene (TSG) silencing. Several recent reports provide compelling evidence of the relevance of genomic hypomethylation in cancer. These findings provide the best evidence so far that links the loss of DNA methylation and chromosomal instability with cancer development. This review article discusses these recent findings and reflects on the antithetical association between DNA methylation and carcinogenesis and the re-examination of studies performed almost two decades ago.
Insights
Genomic hypomethylation, a loss of DNA methylation, is increasingly linked to cancer development and chromosomal instability. This review revisits this critical finding and its implications for understanding carcinogenesis.
Area of Science:
- Epigenetics and Cancer Biology
- Molecular Oncology
Background:
- Genomic methylation changes are crucial in cancer.
- Traditionally, DNA hypermethylation and tumor suppressor gene (TSG) silencing were the focus.
- Recent evidence highlights the significance of genomic hypomethylation in carcinogenesis.
Purpose of the Study:
- To review recent findings on genomic hypomethylation in cancer.
- To discuss the link between DNA hypomethylation and chromosomal instability.
- To re-examine the role of DNA methylation in carcinogenesis.
Main Methods:
- Literature review of recent reports on genomic methylation and cancer.
- Analysis of evidence linking hypomethylation to chromosomal instability.
- Re-evaluation of historical studies on DNA methylation and carcinogenesis.
Main Results:
- Compelling evidence supports the relevance of genomic hypomethylation in cancer.
- Loss of DNA methylation is strongly associated with chromosomal instability.
- These findings provide robust evidence for hypomethylation's role in cancer development.
Conclusions:
- Genomic hypomethylation is a significant factor in cancer development.
- The antithetical association between DNA methylation and carcinogenesis warrants re-examination.
- Understanding hypomethylation is crucial for cancer research and therapy.
Related Concept Videos
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

